pMKO.1 puro p53 shRNA 2 Citations (13)
Originally described in: Telomerase maintains telomere structure in normal human cells.Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC Cell. 2003 Jul 25. 114(2):241-53. PubMed Journal
Articles Citing pMKO.1 puro p53 shRNA 2
Articles |
---|
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
Gewinner C, Wang ZC, Richardson A, Teruya-Feldstein J, Etemadmoghadam D, Bowtell D, Barretina J, Lin WM, Rameh L, Salmena L, Pandolfi PP, Cantley LC.
Cancer Cell. 2009 Aug 4. 16(2):115-25.
PubMed
Associated Plasmids |
Growth factor-antagonized rexinoid apoptosis involves permissive PPARgamma/RXR heterodimers to activate the intrinsic death pathway by NO. Shankaranarayanan P, Rossin A, Khanwalkar H, Alvarez S, Alvarez R, Jacobson A, Nebbioso A, de Lera AR, Altucci L, Gronemeyer H. Cancer Cell. 2009 Sep 8;16(3):220-31. doi: 10.1016/j.ccr.2009.07.029. PubMed |
Reprogramming of embryonic human fibroblasts into fetal hematopoietic progenitors by fusion with human fetal liver CD34+ cells. Sandler VM, Lailler N, Bouhassira EE. PLoS One. 2011 Apr 14;6(4):e18265. doi: 10.1371/journal.pone.0018265. PubMed |
Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts.
Tanabe K, Nakamura M, Narita M, Takahashi K, Yamanaka S.
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12172-9. doi: 10.1073/pnas.1310291110. Epub 2013 Jun 28.
PubMed
Associated Plasmids |
Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway. Havel JJ, Li Z, Cheng D, Peng J, Fu H. Oncogene. 2015 Mar 19;34(12):1487-98. doi: 10.1038/onc.2014.91. Epub 2014 Apr 7. PubMed |
Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex. Kumar P P, Emechebe U, Smith R, Franklin S, Moore B, Yandell M, Lessnick SL, Moon AM. Elife. 2014 May 29;3. doi: 10.7554/eLife.02805. PubMed |
Regulation of DNA damage responses and cell cycle progression by hMOB2. Gomez V, Gundogdu R, Gomez M, Hoa L, Panchal N, O'Driscoll M, Hergovich A. Cell Signal. 2015 Feb;27(2):326-39. doi: 10.1016/j.cellsig.2014.11.016. Epub 2014 Nov 21. PubMed |
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers. Van Roosbroeck K, Fanini F, Setoyama T, Ivan C, Rodriguez-Aguayo C, Fuentes-Mattei E, Xiao L, Vannini I, Redis R, D'Abundo L, Zhang X, Nicoloso MS, Rossi S, Gonzalez-Villasana V, Rupaimoole R, Ferracin M, Morabito F, Neri A, Ruvolo P, Ruvolo VR, Pecot CV, Amadori D, Aruzzo L, Calin S, Wang X, You MJ, Ferrajoli A, Orlowski RZ, Plunkett W, Lichtenberg T, Davuluri RV, Berindan-Neagoe I, Negrini M, Wistuba II, Hagop K, Sood AK, Lopez-Berestein G, Keating MJ, Fabbri M, Calin GA. Clin Cancer Res. 2016 Nov 30. pii: clincanres.1025.2016. PubMed |
Nuclear Envelope Rupture Is Enhanced by Loss of p53 or Rb. Yang Z, Maciejowski J, de Lange T. Mol Cancer Res. 2017 Nov;15(11):1579-1586. doi: 10.1158/1541-7786.MCR-17-0084. Epub 2017 Aug 15. PubMed |
Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma. Luanpitpong S, Angsutararux P, Samart P, Chanthra N, Chanvorachote P, Issaragrisil S. Sci Rep. 2017 Sep 6;7(1):10607. doi: 10.1038/s41598-017-10886-x. PubMed |
Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy. Pan R, Ruvolo V, Mu H, Leverson JD, Nichols G, Reed JC, Konopleva M, Andreeff M. Cancer Cell. 2017 Dec 11;32(6):748-760.e6. doi: 10.1016/j.ccell.2017.11.003. PubMed |
Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity. Oikawa T, Otsuka Y, Onodera Y, Horikawa M, Handa H, Hashimoto S, Suzuki Y, Sabe H. Sci Rep. 2018 Jan 25;8(1):1595. doi: 10.1038/s41598-018-20043-7. PubMed |
Epithelial p53 Status Modifies Stromal-Epithelial Interactions During Basal-Like Breast Carcinogenesis. Fuller AM, Yang L, Hamilton AM, Pirone JR, Oldenburg AL, Troester MA. J Mammary Gland Biol Neoplasia. 2021 Jan 13. pii: 10.1007/s10911-020-09477-w. doi: 10.1007/s10911-020-09477-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.